In memory of Kristin Page 1974–2024 - Scorecard - MDSpire

In memory of Kristin Page 1974–2024

  • By

  • Larisa Broglie

  • Elizabeth Siepmann

  • Bronwen Shaw

  • January 3, 2025

  • 0 min

Share

Clinical Scorecard: Honoring the Legacy of Kristin Page (1974–2024)

At a Glance

CategoryDetail
ConditionPediatric cancer and acute leukemia
Key MechanismsAdvancements in cancer research, transplant and cellular therapy data, quality, and informatics
Target PopulationPediatric patients and families affected by cancer and acute leukemia
Care SettingAcademic and clinical research institutions, transplant centers

Key Highlights

  • Kristin Page was a pediatric physician and researcher focused on cancer and acute leukemia, contributing significantly to transplant and cellular therapy data and quality.
  • She co-developed the Working Committee Training and Leadership (WCTL) program to mentor and elevate the next generation of leaders in the field.
  • Kristin was widely recognized for her mentorship, leadership, and collaborative efforts internationally, impacting research and clinical practice.

Guideline-Based Recommendations

Diagnosis

  • Utilize minimal residual disease (MRD) assessment as a practice-changing research focus in acute leukemia.

Management

  • Incorporate data quality and informatics to improve transplant and cellular therapy outcomes.
  • Engage multidisciplinary teams and international collaborations to enhance patient care and research.

Monitoring & Follow-up

  • Implement robust data operations and quality control measures in transplant and cellular therapy registries.

Risks

  • Recognize the challenges in managing acute leukemia and transplant patients requiring ongoing research and data-driven improvements.

Patient & Prescribing Data

Pediatric and adult patients undergoing transplant and cellular therapy for acute leukemia

Data-driven approaches and quality improvements in transplant and cellular therapy can enhance patient outcomes.

Clinical Best Practices

  • Foster mentorship and leadership development among early career investigators and clinicians.
  • Promote international collaboration to advance research and clinical care in hematopoietic cell transplantation.
  • Prioritize data quality, informatics, and innovation in transplant and cellular therapy research.

References

Original Source(s)

Related Content